Annotation Detail

Information
Associated Genes
TNFSF10
Associated Variants
TNFSF10 MUTATION
TNFSF10 MUTATION
Associated Disease
ovarian carcinoma
Source Database
DisGeNET
Description
The synergy of AMG655 with Apo2L/TRAIL extended to primary ovarian cancer cells and was further enhanced by combination with the proteasome inhibitor bortezomib or a second mitochondrial-derived activator of caspases (SMAC) mimetic.
Pubmed
24909167
Section of the abstract supporting the evidence
ALL_TEXT_3/3
Number of the section of the abstract supporting the evidence
3
Number of the sentence supporting the evidence
12
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00461451182536516
Drugs